心导管室内心脏骤停的患者特征与生存结局:来自Get With the Guidelines®-复苏登记的研究
该研究基于美国心脏协会Get With the Guidelines®-复苏登记,纳入2000-2019年428家医院中年龄≥18岁、在心导管室、ICU或手术室发生院内心脏骤停的患者,采用分层多因素logistic回归比较出院生存率。共193,950例,中心导管室6,865例、ICU 181,905例、手术室5,180例;心导管室出院生存2,614例(38.1%),ICU 30,830例(16.9%),手术室2,096例(40.5%)。校正后,心导管室骤停者出院生存率高于ICU(OR 1.37,95%CI 1.29-1.46,p<0.001),但低于手术室(OR 0.81,95%CI 0.69-0.94,p=0.006)。作者认为心导管室与手术室骤停均为目击且反应时间应相似,生存差异的原因需进一步研究。
要点
- 心导管室院内心脏骤停出院生存2,614/6,865例(38.1%),手术室2,096/5,180例(40.5%),ICU 30,830/181,905例(16.9%)。
- 校正后心导管室骤停者出院生存率高于ICU(OR 1.37,95%CI 1.29-1.46,p<0.001)。
- 校正后心导管室骤停者出院生存率低于手术室(OR 0.81,95%CI 0.69-0.94,p=0.006)。
- 心导管室与手术室骤停均为目击事件且反应时间应相似,作者认为生存差异的原因需进一步研究。
适用人群与场景
- 美国心脏协会Get With the Guidelines®-复苏登记中2000-2019年428家医院年龄≥18岁、在心导管室、ICU或手术室发生院内心脏骤停的患者。
研究设计与关键结果
- 研究类型为基于Get With the Guidelines®-复苏登记的分析,纳入428家医院193,950例年龄≥18岁院内心脏骤停患者,中心导管室6,865例、ICU 181,905例、手术室5,180例。
- 心导管室出院生存2,614例(38.1%),ICU 30,830例(16.9%),手术室2,096例(40.5%)。
- 校正后心导管室骤停者出院生存率高于ICU(OR 1.37,95%CI 1.29-1.46,p<0.001)。
- 校正后心导管室骤停者出院生存率低于手术室(OR 0.81,95%CI 0.69-0.94,p=0.006)。
证据类型、等级与局限
- 证据类型:基于美国心脏协会Get With the Guidelines®-复苏登记的分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为心导管室与手术室骤停均为目击且反应时间应相似,生存差异的原因需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Characteristics and outcomes of patients with in-hospital cardiac arrest (IHCA) in the cardiac catheterization laboratory (CCL) have not been well-described. Thus, we compared the outcomes of patients with an IHCA in the CCL versus those in the intensive care unit (ICU) and operating rooms (OR).
METHODS: Within the American Heart Association's Get With the Guidelines®-Resuscitation registry, we identified patients ≥ 18 years old with IHCA in the CCL, ICU, or OR between 2000-2019. Using hierarchical multivariable logistic regression, we compared rates of survival to discharge for patients with IHCA in the CCL versus ICU and OR.
RESULTS: Across 428 hospitals, 193,950 patients had IHCA, of whom 6865, 181,905 and 5180 were in the CCL, ICU and OR, respectively. Overall, 2614 (38.1%) patients with IHCA in the CCL survived to discharge, whereas 30,830 (16.9%) and 2096 (40.5%) survived to discharge from the ICU and OR, respectively. After adjustment, patients with IHCA in CCL were more likely to survive to discharge as compared to those with IHCA in the ICU (odds ratio, 1.37 [95%CI: 1.29-1.46], p < 0.001). In contrast, those who had IHCA in the CCL were less likely to survive to discharge as compared to patients with IHCA in the OR (odds ratio, 0.81 [95%CI: 0.69-0.94], p = 0.006).
CONCLUSION: IHCA in the CCL is not uncommon and has a lower survival rate when compared with IHCA in the OR. The reasons for this difference deserve further study given that cardiac arrest in both settings is witnessed and response time should be similar.
参考来源
- Elkaryoni A, Tran AT, Saad M, et al. Patient characteristics and survival outcomes of cardiac arrest in the cardiac catheterization laboratory: Insights from get with the Guidelines®-Resuscitation registry. Resuscitation. 2022. PMID: 35944818. doi:10.1016/j.resuscitation.2022.08.002
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。